Curtis Tyree, PhD

Senior Vice President, Strategic Planning

Dr. Tyree is responsible for the strategic goal and resource management of candidates from HUYABIO’s China-sourced therapeutic R&D engine. With over 25 years experience, he has worked on projects at Ligand Pharmaceuticals, TorreyPines Therapeutics, Abbott, GlaxoSmithKline, Bristol-Myers Squibb, and Eisai. Curtis contributed to the discovery of Promacta, the first oral thrombopoietin receptor agonist and the first published gamma secretase modulator for Alzheimer’s. Previously an advisor to China’s Hangzhou High Tech Incubator, he is currently Adjunct Clinical Assistant Professor of Pharmacy Practice and Advisory Board member at KGI School of Pharmacy and Health Sciences. Dr. Tyree received a BSc from McGill University and a PhD in Biology from UCSD, performing his postdoctoral cancer research at the McArdle Laboratory at UW Madison.